CAPLIPOINT

Caplin Point Laboratories LimitedNSE
₹2,770.1-43.90 (-1.56%)

Market Closed · NSE · INR

Open

₹2,830

High

₹2,850.4

Low

₹2,747.1

Prev Close

₹2,814

52-Week Range94% from low
₹1,504.8
₹2,845

Market Cap

₹21.39 K Cr

Large Cap

P/E (TTM)

32.15

EPS

₹87.53

Div Yield

0.39%

P/B Ratio

5.8

ROE

18.7%

Key Metrics

Forward P/E25.42
Book Value₹477.66
Debt/Equity0.00×
Revenue Growth19.6%
Profit Margin29.64%
Operating Margin34.79%
Volume1.28 L
Avg Volume (20d)2.48 L
Delivery %39.16%
Trades16,826

Analyst Ratings(2 analysts)

-

Target Price

₹2,765

-0.2% upside

Buy2
Low: ₹2,690Median: ₹2,765High: ₹2,840

Current price: ₹2,770

Upcoming Events

Ex-Dividend Date
18 Sept 2026

What If I Had Invested?

Chart data not available for this range

AI Analysis

Get AI-powered sentiment analysis, strengths, risks, and outlook for this stock.

AI Technical Analysis

Buy/sell zones with live web research

Get AI-generated buy zones, sell targets, stop-loss levels and a technical narrative — powered by AI with live web search for the latest news and analyst moves.

Patterns are measured on real price data, then AI-validated. Pattern detection is free when nothing clean is found.

About

HealthcareDrug Manufacturers - Specialty & Generic

Caplin Point Laboratories Limited, together with its subsidiaries, engages in the development, production, marketing, and export of generic formulations and branded products in India. The company provides tablets, capsules, injections, ophthalmic, liquid orals, softgel capsules, ointments, creams an...

caplinpoint.net3,966 employees

Technical Indicators

Loading sector benchmark…

Quality scores

Valuation bands

Intrinsic value calculators

Peer Comparison

Dividend History

Recent: 14.00/share
25
25
26
26
18 Sept 20264.00
29 May 20264.00
12 Sept 20253.00
30 May 20253.00
Loading events…

Recent Filings (NSE)

Raw NSE filings — full text + attachments. Tap any row for an AI summary that explains what it means for the stock.

Institutional Deals(NSE)

Source: NSE India. Block deals ≥5L shares or ≥₹10Cr. Bulk deals ≥0.5% of shares.

Governance Scorecard

AlphaView composite

Fund Actions

Loading fund activity…

News

News sourced from RSS feeds. Headlines link to original articles.

Disclaimer: This is AI-generated educational information, not investment advice. Stock data is delayed by up to 15 minutes. Past performance does not guarantee future results. Please consult a SEBI-registered investment advisor before making investment decisions.